The Search for Anticancer Agents from Tropical Plants

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Drug Discovery

Background:

• Many anticancer drugs originate from natural sources, particularly plants.
• Tropical plant species are recognized for their rich chemical diversity, offering greater potential for novel drug discovery compared to temperate species.
• Ethical and regulatory frameworks, including the Rio Convention and Nagoya Protocol, govern the responsible collection of plant resources.

Purpose of the Study:

• To explore the potential of tropical plant-derived secondary metabolites as anticancer agents.
• To detail the methodologies for responsible plant collection, identification, and phytochemical analysis in drug discovery.
• To present promising anticancer compounds discovered from various tropical regions.

Main Methods:

• Responsible collection and taxonomic identification of plant samples from tropical regions.
• Phytochemical analysis including solvent fractionation, compound dereplication, and activity-guided fractionation.
• In vitro and in vivo testing, including structure determination, analog development, solubility, formulation, and pharmacokinetic studies.

Main Results:

• Identification of promising anticancer compounds from plant species collected in Africa, Southeast Asia, the Americas, and the Caribbean.
• Discovery of secondary metabolites including diphyllin lignans, cyclopenta[b]benzofurans, triterpenoids, and tropane alkaloids with potential anticancer activity.
• Successful application of multidisciplinary research projects in natural product drug discovery.

Conclusions:

• Tropical plants represent a valuable resource for discovering novel anticancer drug candidates.
• Systematic phytochemical investigation and rigorous evaluation are crucial for advancing natural products into clinical development.
• The study underscores the importance of interdisciplinary collaboration and adherence to ethical guidelines in bioprospecting.